Advancements in the Treatment of Myasthenia Gravis: From Traditional Immunotherapies to Novel Biologics
Myasthenia gravis (MG) is a persistent autoimmune illness that damages the neuromuscular junction, weakening skeletal muscular tissues in positive regions. …